Viewing Study NCT03591666

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:25 PM
Ignite Modification Date: 2026-01-05 @ 5:15 PM
Study NCT ID: NCT03591666
Status: UNKNOWN
Last Update Posted: 2018-07-19
First Post: 2018-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas
Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Carcinoma View
None Adenocarcinoma View
None Recurrent Disease View
None Distantly Metastatic Malignant Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None head and neck adenocarcinoma View
None Anlotinib View